PCI Biotech Holding
PCIB | OL
Overview
Corporate Details
- ISIN(s):
- NO0010405640
- LEI:
- 5967007LIEEXZXFIGG77
- Country:
- Norway
- Address:
- Ullernchausséen 64, 0379 OSLO
- Website:
- https://www.pcibiotech.no/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
PCI Biotech (OSE:PCIB) is a biopharmaceutical company focusing on development and commercialisation of novel therapeutic solutions for improved treatment of cancer patients through its innovative photochemical internalisation (PCI) technology platform. PCI induces triggered endosomal release that can be used to unlock the true potential of a wide array of therapeutic modalities. The company is applying PCI to two distinct paradigms: - fimaVACC - Enhanced T-cell induction for therapeutic vaccination - fimaNAC - Nucleic acid therapeutics delivery Clinical proof-of-concept has been achieved in the lead programme fimaVacc, which applies a unique mode of action to enhance the essential cytotoxic effect of therapeutic cancer vaccines. The fimaNAc programme utilises the triggered endosomal release to provide effective intracellular delivery of nucleic acids, such as mRNA and siRNA therapeutics.
Stop Scraping. Start Analyzing.
You're viewing a fraction of the data available for PCI Biotech Holding.
Get complete, real-time, and AI-ready data via the API the pros use.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-05-22 09:45 |
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
|
Norwegian | 449.8 KB | |
| 2025-05-22 09:45 |
Post-Annual General Meeting Information
PCI Biotech: Minutes of Annual General Meeting 2025
|
English | 866 bytes | |
| 2025-05-20 20:08 |
Declaration of Voting Results & Voting Rights Announcements
PCI BIotech: Disclosure of voting rights for Chair of the Board
|
English | 1.2 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
Norwegian | 188.6 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
Norwegian | 146.9 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 167.8 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 208.0 KB | |
| 2025-04-30 08:00 |
Pre-Annual General Meeting Information
Notice of Annual General Meeting 2025
|
English | 977 bytes | |
| 2025-04-24 15:30 |
Annual Report (ESEF)
PCI Biotech Holding ASA: Annual Report 2024
|
English | 5.4 MB | |
| 2025-04-24 15:30 |
Annual Report
PCI Biotech Holding ASA: Annual Report 2024
|
English | 1.2 MB | |
| 2025-04-24 15:30 |
Report Publication Announcement
PCI Biotech Holding ASA: Annual Report 2024
|
English | 908 bytes | |
| 2025-02-27 06:00 |
Investor Presentation
PCI Biotech full year 2024 interim results
|
English | 2.5 MB | |
| 2025-02-27 06:00 |
Interim Report
PCI Biotech full year 2024 interim results
|
English | 978.4 KB | |
| 2025-02-27 06:00 |
Report Publication Announcement
PCI Biotech full year 2024 interim results
|
English | 6.0 KB | |
| 2025-02-25 07:56 |
Report Publication Announcement
PCI Biotech: Invitation to preliminary full-year 2024 results presentation
|
English | 2.9 KB |
Automate Your Workflow. Get a real-time feed of all PCI Biotech Holding filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for PCI Biotech Holding via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
Active Biotech | Sweden | ACTI | |
|
AcuCort AB | Sweden | ACUC |